行情

ISEE

ISEE

IVERIC bio Inc
NASDAQ

实时行情|Nasdaq Last Sale

3.170
+0.020
+0.63%
已收盘, 16:00 11/14 EST
开盘
3.120
昨收
3.150
最高
3.350
最低
3.100
成交量
56.62万
成交额
--
52周最高
4.360
52周最低
0.9059
市值
1.32亿
市盈率(TTM)
2.035
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ISEE 新闻

  • 沪指周跌2.46% 隔夜美联储官员密集讲话
  • 新浪财经.2小时前
  • 看中国论坛:双11是彰显中国消费信心的窗口
  • 新浪财经.7小时前
  • 美国家庭债务规模创纪录高位 四张图带你详细了解
  • 新浪财经综合.7小时前
  • 西铁城精机在中国建新厂生产自动车床 产能翻番
  • 新浪财经综合.8小时前

更多

所属板块

生物技术和医学研究
-0.05%
制药与医学研究
-0.27%

热门股票

名称
价格
涨跌幅

ISEE 简况

IVERIC bio, Inc., formerly Ophthotech Corporation, is a biopharmaceutical company. The Company is focused on the discovering and developing of novel gene therapy solutions to treat orphan inherited retinal diseases, with a focus on diseases of the back of the eye. Its primary focus is developing therapeutics for age-related macular degeneration (AMD), which is a disorder of the central portion of the retina, known as the macula, that may result in blindness. The Company’s BEST1 gene encodes a multifunctional protein known as bestrophin1, that regulates ion transport and intracellular calcium signaling in retina cells and helps maintain homeostasis in the sub retinal space between photoreceptors and the retinal pigment epithelial (RPE) cells. Its IC-200 is a mutation independent gene therapy, delivered by an AAV2 vector.
展开

Webull提供IVERIC bio Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。